| mRNA |
TKI258 |
CCLE |
pan-cancer |
AAC |
0.2 |
2e-05 |
| mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0001 |
| mRNA |
BMS-270394 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0006 |
| mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.0007 |
| mRNA |
Bortezomib |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.001 |
| mRNA |
Bexarotene |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.001 |
| mRNA |
ATRA |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
| mRNA |
Sorafenib |
CCLE |
pan-cancer |
AAC |
0.15 |
0.002 |
| mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
| mRNA |
AM-580 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.003 |